Today's Updates
The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.
Oncology
Comprehensive review of patient care after organ-preserving cancer interventions for healthcare professionals.
Comprehensive review on quality of life and functional reintegration after organ-conserving cancer therapies for healthcare professionals.
Comprehensive review on enhancing quality of life through precision functional recovery after organ-preserving interventions.
Review of tumor evolutionary trajectory modeling in precision oncology, mechanisms, clinical relevance, and future directions.
Dr. Harish P and 1 more
Dr. Vijay Agarwal and 1 more
Dr Suvir Singh
Dr Vijay Agarwal and 1 more
Dr. Todd Bauer and 1 more
Dr. Poonam Patil and 1 more
Fastest Growing Medical Platform for Doctors
Address : Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone : +1-415-463-3094
Email : anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
To get started please enter your email ID
By entering your details you agree to our
Please check your email for the four-digit security code and enter it below.
Didn't receive a code? Resend OTP
Join to enhance your clinical skills and gain specialized in-depth medical knowledge
Country
State
64824 This Month
2524 Today